Literature DB >> 15179447

Pharmacological effects of xanthones as cardiovascular protective agents.

De-Jian Jiang1, Zhong Dai, Yuan-Jian Li.   

Abstract

Many epidemiological studies indicate that consumption of dietary polyphenolic compounds is beneficial in the prevention of cardiovascular diseases. Xanthones are a class of polyphenolic compounds that commonly occur in plants and have been shown to have extensive biological and pharmacological activities. Recently, the pharmacological properties of xanthones in the cardiovascular system have attracted great interest. Xanthones and xanthone derivatives have been shown to have beneficial effects on some cardiovascular diseases, including ischemic heart disease, atherosclerosis, hypertension and thrombosis. The protective effects of xanthones in the cardiovascular system may be due to their antioxidant, antiinflammatory, platelet aggregation inhibitory, antithrombotic and/or vasorelaxant activities. In particular, the antagonism of endogenous nitric oxide synthase inhibitors by xanthones may represent the basis for improved endothelial function and for reduction of events associated with atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15179447     DOI: 10.1111/j.1527-3466.2004.tb00133.x

Source DB:  PubMed          Journal:  Cardiovasc Drug Rev        ISSN: 0897-5957


  11 in total

1.  2,3-Diarylxanthones as Potential Inhibitors of Arachidonic Acid Metabolic Pathways.

Authors:  Clementina M M Santos; Daniela Ribeiro; Artur M S Silva; Eduarda Fernandes
Journal:  Inflammation       Date:  2017-06       Impact factor: 4.092

Review 2.  Novel Insights on Dietary Polyphenols for Prevention in Early-Life Origins of Hypertension: A Review Focusing on Preclinical Animal Models.

Authors:  You-Lin Tain; Chien-Ning Hsu
Journal:  Int J Mol Sci       Date:  2022-06-14       Impact factor: 6.208

3.  Leishmanicidal and cholinesterase inhibiting activities of phenolic compounds from Allanblackia monticola and Symphonia globulifera.

Authors:  Bruno Ndjakou Lenta; Catherine Vonthron-Sénécheau; Bernard Weniger; Krishna Prasad Devkota; Joseph Ngoupayo; Marcel Kaiser; Qamar Naz; Muhammad Iqbal Choudhary; Etienne Tsamo; Norbert Sewald
Journal:  Molecules       Date:  2007-07-20       Impact factor: 4.411

4.  Prenylated xanthones from mangosteen (Garcinia mangostana) activate the AhR and Nrf2 pathways and protect intestinal barrier integrity in HT-29 cells.

Authors:  Restituto Tocmo; Bryan Le; Amber Heun; Jan Peter van Pijkeren; Kirk Parkin; Jeremy James Johnson
Journal:  Free Radic Biol Med       Date:  2020-12-09       Impact factor: 7.376

5.  2-Methylxanthen-9-one.

Authors:  N Vinutha; Sumati Anthal; V Lakshmi Ranganatha; Shaukath Ara Khanum; D Revannasiddaiah; Rajni Kant; Vivek K Gupta
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-02-29

6.  Screening of Antioxidant Activity of Gentian Lutea Root and Its Application in Oil-in-Water Emulsions.

Authors:  Nurul Aini Mohd Azman; Francisco Segovia; Xavier Martínez-Farré; Emilio Gil; María Pilar Almajano
Journal:  Antioxidants (Basel)       Date:  2014-06-19

7.  Evaluation of Mangosteen juice blend on biomarkers of inflammation in obese subjects: a pilot, dose finding study.

Authors:  Jay K Udani; Betsy B Singh; Marilyn L Barrett; Vijay J Singh
Journal:  Nutr J       Date:  2009-10-20       Impact factor: 3.271

8.  Antileptospiral activity of xanthones from Garcinia mangostana and synergy of gamma-mangostin with penicillin G.

Authors:  Weeranuch Seesom; Amornmart Jaratrungtawee; Sunit Suksamrarn; Chantana Mekseepralard; Piniti Ratananukul; Wasana Sukhumsirichart
Journal:  BMC Complement Altern Med       Date:  2013-07-19       Impact factor: 4.782

9.  Antitumor and apoptosis-inducing effects of α-mangostin extracted from the pericarp of the mangosteen fruit (Garcinia mangostana L.)in YD-15 tongue mucoepidermoid carcinoma cells.

Authors:  Hae Nim Lee; Hye Yeon Jang; Hyeong Jin Kim; Seong Ah Shin; Gang Sik Choo; Young Seok Park; Sang Ki Kim; Ji Youn Jung
Journal:  Int J Mol Med       Date:  2016-03-04       Impact factor: 4.101

10.  Anti-allodynic Effect of Mangiferin in Rats With Chronic Post-ischemia Pain: A Model of Complex Regional Pain Syndrome Type I.

Authors:  Bárbara B Garrido-Suárez; Gabino Garrido; Marian Castro-Labrada; Zenia Pardo-Ruíz; Addis Bellma Menéndez; Evelyn Spencer; Jozi Godoy-Figueiredo; Sergio H Ferreira; René Delgado-Hernández
Journal:  Front Pharmacol       Date:  2018-10-02       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.